GRHL3 Promotes Tumor Growth and Metastasis via the MEK Pathway in Colorectal Cancer
GRHL3 is a factor associated with a tumor, of which the molecular mechanism remains a further investigation. We explored the underlying mechanism of tumor-promoting effect of GRHL3 in colorectal cancer (CRC), which is involved in the MEK1/2 pathway. The expression of GRHL3 was measured in CRC and ad...
Saved in:
Main Authors: | Lin Tan, Weiming Qu, Dajun Wu, Minji Liu, Qian Wang, Qiongjia Ai, Hongsai Hu, Min Chen, Weishun Chen, Hongbing Zhou |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-01-01
|
Series: | Analytical Cellular Pathology |
Online Access: | http://dx.doi.org/10.1155/2021/6004821 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
MEK1/2 Inhibitor (GDC0623) Promotes Osteogenic Differentiation of Primary Osteoblasts Inhibited by IL-1β through the MEK-Erk1/2 and Jak/Stat3 Pathways
by: Zeng-Qiao Zhang, et al.
Published: (2021-01-01) -
Retracted: Abnormal GRHL2 Methylation Confers Malignant Progression to Acute Leukemia
by: Applied Bionics and Biomechanics
Published: (2023-01-01) -
Nicotine-induced CHRNA5 activation modulates CES1 expression, impacting head and neck squamous cell carcinoma recurrence and metastasis via MEK/ERK pathway
by: Chen Feng, et al.
Published: (2024-10-01) -
Inhibition of MEK1 Signaling Pathway in the Liver Ameliorates Insulin Resistance
by: Atsunori Ueyama, et al.
Published: (2016-01-01) -
HAVCR1 Affects the MEK/ERK Pathway in Gastric Adenocarcinomas and Influences Tumor Progression and Patient Outcome
by: Ji Xue, et al.
Published: (2019-01-01)